Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDIS: Reduction of Immunosuppression in Kidney Transplant Recipients in ICU
NCT06881927Phase 4Recruiting
- Sponsor
- Strasbourg University Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in septic shock and acute respiratory failure (ARF) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Rate of patients showing a change in the SOFA (Sequential Organ Failure Assessment) score of at least 4 points at 5 days. Started Aug 2026; status: recruiting.
02
Conditions
septic shockacute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT06881927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06881927.